IMT-009

· Immunitas Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMT-009, covering 2025-10-16 to 2025-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]